Tefferi, Ayalew

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

Levine, R. L., Wadleigh, M., Cools, J., Ebert, B. L., Wernig, G., Huntly, B. J. P., Boggon, T. J., Wlodarska, I., Clark, J. J., Moore, S., et al. (2005) · Cancer Cell

Myeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia Research

Cited by 2,993

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Arber, D. A., Orazi, A., Hasserjian, R. P., Borowitz, M. J., Calvo, K. R., Kvasnicka, H.-M., Wang, S. A., Bagg, A., Barbui, T., Branford, S., et al. (2022) · Blood

Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes

Cited by 2,945

Mesenteric Venous Thrombosis

Singal, A. K., Kamath, P. S., & Tefferi, A. (2013) · Mayo Clinic Proceedings

Abdominal vascular conditions and treatmentsVenous Thromboembolism Diagnosis and Management

Cited by 389

Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases

Mesa, R. A., Li, C.-Y., Ketterling, R. P., Schroeder, G. S., Knudson, R. A., & Tefferi, A. (2005) · Blood

Myeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia Research

Cited by 389

Plasma cytokines in polycythemia vera: Phenotypic correlates, prognostic relevance, and comparison with myelofibrosis

Vaidya, R., Gangat, N., Jimma, T., Finke, C. M., Lasho, T. L., Pardanani, A., & Tefferi, A. (2012) · American Journal of Hematology

Myeloproliferative Neoplasms: Diagnosis and TreatmentPlatelet Disorders and Treatments

Cited by 149

Mutation in TET2 in Myeloid Cancers

Tefferi, A., Lim, K. H., & Levine, R. L. (2009) · New England Journal of Medicine

Acute Myeloid Leukemia ResearchCancer Genomics and Diagnostics

Cited by 66

Estrogen-based hormone therapy and thrombosis risk in women with essential thrombocythemia

Gangat, N., Wolanskyj, A. P., Schwager, S. M., Mesa, R. A., & Tefferi, A. (2006) · Cancer

Myeloproliferative Neoplasms: Diagnosis and TreatmentPlatelet Disorders and Treatments

Cited by 37

Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations

Shah, M. V., Hung, K., Baranwal, A., Kutyna, M. M., Al-Kali, A., Toop, C., Greipp, P., Brown, A., Shah, S., Khanna, S., et al. (2025) · Blood Advances

Acute Myeloid Leukemia ResearchChronic Myeloid Leukemia Treatments

Cited by 23

Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases

Abdelmagid, M. G., Litzow, M. R., McCullough, K. B., Gangat, N., Pardanani, A., Murthy, H. S., Foran, J. M., Ketterling, R. P., Viswanatha, D., Begna, K. H., et al. (2022) · Blood Cancer Journal

Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research

Cited by 13